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Mutant Cullin causes cardiovascular
compromise
Friedrich C Luft
Mendelian hypertension is rare; however,
Mendelian syndromes have taught us an
amazing amount about mechanisms of
distal sodium and chloride reabsorption,
as well as how systemic hypertension
might come about. In this issue of EMBO
Molecular Medicine, Schumacher et al (2015)
present a mouse model of the Cullin-3
(CUL3D403–459) mutation, which causes a
form of pseudohypoaldosteronism type-2
(PHA-2). CUL3 is involved in ubiquitination.
Surprising is the severity of the hyperten-
sion, which may be explained in part on
the basis of CUL3 actions in vascular cells.
The findings underscore the role of
“cleanup” in the maintenance of normal
physiology.
See also: FR Schumacher et al
A n apparent state of renal tubularunresponsiveness or resistance to theaction of aldosterone characterizes a
heterogeneous group of disordered elec-
trolyte metabolism termed pseudohypoal-
dosteronism (PHA). PHA1 is characterized
by sodium wasting, hyperkalemia, as well as
hypotension and will not concern us further
here. PHA2 features sodium retention,
hyperkalemia, mild hyperchloremic meta-
bolic acidosis, and hypertension. Mutations
of the mammalian with-no-lysine kinases
(WNK1 and WNK4) in humans cause PHA2
(Huang & Cheng, 2015). The importance of
this rare and easily treated Mendelian hyper-
tension lies in the pathways uncovered by
this research (Sohara & Uchida, 2015). In
the kidney, the WNK pathways, via protein
odd-skipped-related-1 (OSR1) and STE20/
SPS1-related proline/ alanine-rich kinase
(SPAK) (Rafiqi et al, 2010), are responsible
for sodium-chloride cotransporter (NCC),
sodium-potassium-2chloride transporter (NKCC),
the renal epithelial sodium channel (ENaC),
and renal outer-medullary potassium chan-
nel (ROMK) regulation (Huang & Cheng,
2015; Sohara & Uchida, 2015). ENaC
subunits are ubiquitinated by the neural
precursor cell expressed developmentally
downregulated protein-4 (NEDD4). Failure
of this process can also result in salt-sensitive
hypertension through hyperactivity of ENaC
in the distal nephron.
......................................................
“paracellular pathway is
physiologically regulated
through the ubiquitination
pathway, and its deregulation
may lead to diseases of
electrolyte and blood pressure
imbalances”
......................................................
Pseudohypoaldosteronism type IIE (PHA2E)
is caused by heterozygous mutation in the
CUL3 gene on chromosome 2q36. Boyden
et al used exome sequencing to identify
mutations in Kelch-like 3 (KLHL3) or CUL3
in PHA2 patients from 41 unrelated families
(Boyden et al, 2012). KLHL3 mutations were
either recessive or dominant, whereas CUL3
mutations were dominant and predomi-
nantly de novo. The Kelch motif is composed
of about 50 amino acid residues forming
a four-stranded beta-sheet “blade”. The
sequence motif commonly exists as six or
eight copies per protein forming a circular
solenoid structure called a beta-propeller
domain. The authors suggested that CUL3
and the BTB-domain-containing KLHL3
proteins are components of cullin-really
interesting new gene (RING) E3 ligase
complexes that ubiquitinate substrates
bound to Kelch propeller domains (Boyden
et al, 2012). Ohta et al subsequently
immunoprecipitated KLHL3 and found that
KLHL3 was strongly associated with WNK
isoforms and CUL3, but not with other
components of the pathway regulating NCC
(Ohta et al, 2013). Furthermore, the KLHL3
disease mutations that they analyzed inhib-
ited binding to WNK1 or CUL3. They next
mapped the KLHL3 interaction site in WNK1
to a non-catalytic region. Their results
suggested that the CUL3-KLHL3 E3 ligase
complex regulates blood pressure via inter-
action with, and ubiquitination of WNK
isoforms. Their study revealed how muta-
tions disrupting the ability of an E3 ligase to
interact with and ubiquitinate a critical
cellular substrate such as WNK isoforms can
trigger hypertension.
Shibata et al (2013) next presented find-
ings demonstrating that CUL3-RING ligases
containing KLHL3 target ubiquitination of
WNK4 and thereby regulate WNK4 levels,
which in turn control the levels of ROMK.
These findings revealed a specific role for
CUL3 and KLHL3 in electrolyte homeostasis
and provided a molecular explanation for the
effects of disease-causing mutations in both
KLHL3 and WNK4. McCormick et al (2014)
then demonstrated that a PHA2E-causing
CUL3 mutant (CUL3D403–459) not only
retained the ability to bind and ubiquitinate
WNK kinases and KLHL3 in cells, but also
was more heavily “NEDD”ylated and acti-
vated than wild-type CUL3. In their studies,
nephron-specific deletion of Cul3 in mice
increased WNK levels and the abundance of
phosphorylated NCC. However, over time,
the Cul3 deletion caused renal dysfunction,
including hypochloremic alkalosis, diabetes
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insipidus and salt-sensitive hypotension,
with depletion of NKCC2 and aquaporin 2.
Gong et al (2015) next reported the
identification of claudin-8 as a previously
unidentified physiologic target for KLHL3.
They provided an alternative explanation for
the collecting duct’s role in PHA2. They found
that deletion of claudin-8 in the collecting
duct of mouse kidney caused hypotension,
hypokalemia, and metabolic alkalosis, an
exact mirror image of PHA2. Responsible
for the PHA-2 phenotype was disruption of
the claudin-8 interaction with claudin-4, the
paracellular chloride channel, and delocal-
ization of claudin-4 from the tight junction.
Their findings have added the concept that
the paracellular pathway is physiologically
regulated through the ubiquitination path-
way, and its deregulation may lead to
diseases of electrolyte and blood pressure
imbalances.
Now, in this issue of EMBO Molecular
Medicine, Schumacher et al (2015) report
that the same CUL3D403–459 mutation stud-
ied by McCormick et al (2014) is severely
compromised in its ability to ubiquitinate
WNKs, possibly due to altered structural
flexibility. Instead, CUL3D403–459 auto-
ubiquitinates and loses interaction with two
CUL3 regulators, namely the COP9-Signalo-
some and cullin-associated and neddylation-
dissociated 1 (CAND1). They used a novel
knock-in mouse model of CUL3WT/D403–
459 to recapitulate the human PHA2E
phenotype. Their mice also displayed
changes in arterial pulse waveform, suggest-
ing a vascular contribution to hypertension
not previously appreciated. Their results
imply an explanation for the severity of
PHA2E phenotype caused by CUL3 muta-
tions compared to mutations in KLHL3 or
the WNKs. Particularly exciting is the notion
that the hypertension in this model is not
only the result of increased sodium reab-
sorption but also related to an increased
contractile state in the vascular tree. Addi-
tional studies could be conducted in this
model to pursue this possibility further.
Interestingly, CUL3 was found to regulate
vascular smooth muscle function and blood
pressure via PPARc and RhoA/Rho-kinase
in an earlier study (Pelham et al, 2012).
Furthermore, perivascular supporting cells
in the eye, including smooth muscle cell/
pericytes, have been investigated regarding
proteasome activity. Aghdam et al showed
that retinal endothelial cells have signifi-
cantly higher proteasome peptidase activity
compared to smooth muscle pericytes. High-
glucose treatment increased the level of total
ubiquitin-conjugated proteins in cultured
retinal smooth muscle pericytes and
endothelial cells. Diabetic mice had higher
levels of PA28-b/-c, Cul1 and Cul3 proteins
in their intraglomerular capillaries in that
study (Aghdam et al, 2013). CUL3-related
WNK
Ub
Ub
NEDD
ENaC
Ub
Ub
Ub
Ub
Ub
Ub
KLHL3
WNK
Cul3
Ub
WNK1
WNK4
NCC
P
OSR1
SPAK
P
Na+ Na
+
Na+
Na+
Cl—
Cl—
Cl—
Cl—
Cl—
Distal nephronUrine Blood
DEGRADATION
Figure 1. Regulation of WNK signaling by KLHL3–CUL3 complex.
Under normal conditions, protein levels of WNK1 and WNK4 in DCT are maintained by degradation through
ubiquitination by the KLHL3–CUL3 E3 ligase complex. NEDD is responsible for ENaC disposal, also by
ubiquitination (left). WNK1 and WNK4 regulate OSR1 and SPAK, which in turn regulate NCC, all for the purpose
of sodium and chloride reabsorption.
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Figure 2. All hypertension requires an increase in peripheral vascular resistance to be sustained.
In PHA2, NaCl absorption is increased, while K+ and H+ secretion are impaired. CUL3 mutations impair
ubiquitination of WNK. The current findings suggest that the disease may not be merely a renal affair but could
directly involve regulation of peripheral vascular resistance.
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mechanisms in the vasculature that contri-
bute to hypertension appear worthy of
pursuit.
......................................................
“hypertension in this model is
not only the result of increased
sodium reabsorption but also
related to an increased
contractile state in the
vascular tree”
......................................................
To persons outside the field, “it’s hard
to tell the players without a score card”. A
crude attempt at some of the players at
least is shown (Fig 1). Suffice it to say that
Mendelian forms of hypertension are few in
number. Interestingly, at least three
syndromes, involving KLHL3, CUL3, and
NEDD4, involve failure of proper ubiquiti-
nation (garbage disposal). Clear for all to
see is what happens when the garbage
workers go out on strike! For persons
inside the field, matters are no easier.
Hypertension features increased blood pres-
sure with normal cardiac output, and there-
fore, peripheral vascular resistance must be
increased (Fig 2). PHA2 clearly occurs
inside the kidneys, but how increased NaCl
reabsorption leads to increased peripheral
vascular resistance is not all that clear. The
novel suggestion that the blood vessels
themselves could contribute, leading to
failed vasodilation at high salt intake, could
be very helpful in that regard.
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